Skip to main content
Erschienen in: Clinical Research in Cardiology 12/2020

Open Access 06.07.2020 | Original Paper

Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity

verfasst von: Sven Fikenzer, T. Uhe, D. Lavall, U. Rudolph, R. Falz, M. Busse, P. Hepp, U. Laufs

Erschienen in: Clinical Research in Cardiology | Ausgabe 12/2020

Abstract

Background

Due to the SARS-CoV2 pandemic, medical face masks are widely recommended for a large number of individuals and long durations. The effect of wearing a surgical and a FFP2/N95 face mask on cardiopulmonary exercise capacity has not been systematically reported.

Methods

This prospective cross-over study quantitated the effects of wearing no mask (nm), a surgical mask (sm) and a FFP2/N95 mask (ffpm) in 12 healthy males (age 38.1 ± 6.2 years, BMI 24.5 ± 2.0 kg/m2). The 36 tests were performed in randomized order. The cardiopulmonary and metabolic responses were monitored by ergo-spirometry and impedance cardiography. Ten domains of comfort/discomfort of wearing a mask were assessed by questionnaire.

Results

The pulmonary function parameters were significantly lower with mask (forced expiratory volume: 5.6 ± 1.0 vs 5.3 ± 0.8 vs 6.1 ± 1.0 l/s with sm, ffpm and nm, respectively; p = 0.001; peak expiratory flow: 8.7 ± 1.4 vs 7.5 ± 1.1 vs 9.7 ± 1.6 l/s; p < 0.001). The maximum power was 269 ± 45, 263 ± 42 and 277 ± 46 W with sm, ffpm and nm, respectively; p = 0.002; the ventilation was significantly reduced with both face masks (131 ± 28 vs 114 ± 23 vs 99 ± 19 l/m; p < 0.001). Peak blood lactate response was reduced with mask. Cardiac output was similar with and without mask. Participants reported consistent and marked discomfort wearing the masks, especially ffpm.

Conclusion

Ventilation, cardiopulmonary exercise capacity and comfort are reduced by surgical masks and highly impaired by FFP2/N95 face masks in healthy individuals. These data are important for recommendations on wearing face masks at work or during physical exercise.
Hinweise
Sven Fikenzer and T. Uhe contributed equally.
A comment to this article is available online at https://​doi.​org/​10.​1007/​s00392-020-01725-7.
A comment to this article is available online at https://​doi.​org/​10.​1007/​s00392-020-01735-5.

Introduction

Following the outbreak of the SARS-CoV2 pandemic, use of face masks (fm) is widely recommended by international, national and local authorities [13]. The aim of the regulations is to reduce the respiratory droplet excretion in pre-symptomatic and asymptomatic individuals (source control). The evidence for face masks to reduce respiratory virus infections or to improve clinical outcomes is heterogeneous [46]. The role of fine-particle aerosols and environmental factors such as temperature and humidity on respiratory virus transmission is a matter of scientific debate [7]. However, as long as no effective treatment or vaccination against SARS-CoV2 is available, health policies need to rely on non-pharmacological interventions such as social distancing, intensified hand hygiene and the wearing of face masks. Current recommendations to wear a face mask during times of contact to other individuals affect millions of persons. Especially health care professionals are required to wear masks for long periods of time. However, the quantitative effects of medical masks on cardiopulmonary exercise capacity have never been systematically reported.
Disposable surgical masks are intended to reduce transmissions from the wearer to the patient, hand-to-face contact and facial contact with large droplets. FFP2/N95 facepiece respirators meet filtration requirements of small airborne particles, fit tightly to the wearer’s face and have been suggested to be more efficacious than surgical masks in reducing exposure to viral infections [8]. They are, therefore, widely used by health care professionals for self-protection, especially during the SARS-CoV2 pandemic. However, randomized trials did not find significant differences between FFP2/N95 and surgical masks in preventing influenza infections or respiratory illness [9, 10].
Studies on cardiopulmonary capacity have been performed using respirator masks, e.g., full facepiece masks, filtering air-purifying respirators (APR), air-supplied respirators, blower powered air-purifying respirators (PAPR), and self-contained breathing apparatus (SCBA) [11]. These respirators are better known as “gas masks that are not used by health care professionals and are not suitable to be worn by the majority of the population. Data on cardiopulmonary capacity wearing medical masks are not available. Since surgical and FFP2/N95 masks are the two most widely used types of medical face masks, they were included in this study protocol.
In addition to health care professionals, information on cardiopulmonary effects of face masks in healthy adults could be important for different groups of individuals. Virus particles in respiratory droplets may be transmitted to a greater extent during different forms of physical exertion, many amateur and professional sports or activities such as singing [6, 12]. Face masks have, therefore, been discussed as means to engage in these activities for a wide range of individuals. Therefore, this randomized cross-over study aimed to provide a detailed quantification of the effect of surgical and FFP2/N95 masks on pulmonary and cardiac capacity in healthy adults.

Materials and methods

Subjects

The study was conducted at the Department of Cardiology, University of Leipzig. The 12 active and healthy male volunteers were recruited from medical staff. Subjects with cardiac, pulmonary or inflammatory diseases or any other medical contraindications were not included. The characteristics of the participants are shown in Table 1. The study was conducted in accordance with the latest revision of the Declaration of Helsinki and was approved by the Ethical Committee of the Medical Faculty, University of Leipzig (reference number 088/18-ek). Written informed consent was obtained from all the participants.
Table 1
Baseline characteristics
Parameter
Unit
Mean ± SD
Age
Years
38.1 ± 6.2
Height
cm
183 ± 7.7
Weight
kg
81.8 ± 8.4
Body mass index
kg/m2
24.5 ± 2.0
Sports activity
min/week
186 ± 13
Heart rate
bpm
68.1 ± 9.3
Systolic blood pressure
mmHg
126 ± 13.8
Diastolic blood pressure
mmHg
83.1 ± 6.5
min minute, bpm beats per minute

Study design

Medical history was taken using a questionnaire. Subjects received physical examination and vital parameters, body measurements and a resting electrocardiogram (ECG). Each subject performed three incremental exertion tests (IET), one “no mask” (nm), one with surgical mask (sm) and one with FFP2/N95 mask (ffpm). The order of the masks worn was randomly assigned using the GraphPad Quickcalcs online randomization tool [13]. Tests were performed at the same time of day with a minimum of 48 h between two tests. To assess baseline respiratory function, spirometry for each setting (nm, sm, ffpm) was performed. The participants were blinded with regard to their respective test results to avoid influence by an anticipation bias. Statistical analysis was performed by an independent and fully blinded scientist who was not involved in the conduction of the tests.

Incremental exertion test (IET)

IET were performed on a semi-recumbent ergometer (GE eBike, GE Healthcare GmbH, Solingen, Germany, Germany) at a constant speed of 60–70 revolutions per minute (rpm). The test began at a workload of 50 W with an increase of 50 W within 3 min (as a ramp) until voluntary exhaustion occurred. Each subject continued for an additional 10-min recovery period at a workload of 25 W.

Masks

We used typical and widely used disposable FFP2/N95 protective face masks (Shaoguan Taijie Protection Technology Co., Ltd., Gao Jie, China) and surgical masks (Suavel® Protec Plus, Meditrade, Kiefersfelden, Germany), both with earloops.
The spirometry mask was placed over the fm and fixed with head straps in a leak-proof manner (see Fig. 1A1, B1). After fitting the spirometry mask, subjects performed (a) inspiration and (b) expiration with maximal force. During both maneuvers, the valve of the mask was closed leading to abrupt stop of the air flow (see Fig. 1A2, B2). The fitting was carefully checked for the absence of any acoustic, sensory or visual indication of leakage (e.g., lifting of the mask, whistling or lateral airflow) by the investigators and the test person. The correct fitting and leak tightness were confirmed before each test was started.

Measurements

Cardiac output (CO), stroke volume (SV) (measured by impedance cardiography; Physioflow, Manatec Biomedical, Macheren, France), heart rate (HR) (GE-Cardiosoft, GE Healthcare GmbH, Solingen, Germany), maximum oxygen consumption (VO2max) and minute ventilation (VE) were monitored continuously at rest, during IET and during recovery. Lung function and spirometry data were collected through a digital spirometer (Vyntus™ CPX, Vyaire Germany, Hoechberg, Germany). For each modality (nm, sm, ffpm), data of three expiratory maneuvers with 1‐min intervals were collected using the best values obtained for maximum forced vital capacity (FVC), forced expiratory volume in 1st second (FEV1), peak expiratory flow (PEF) and Tiffeneau index (TIFF). The arterio-venous oxygen difference was computed using Fick’s principle with avDO2 = VO2/CO. Cardiac work (CW) was measured in joules (J) and calculated according to the formula CW = SV (in m3) × SBP (in Pa). Capillary blood samples (55 µl) were taken from the earlobe at baseline and immediately after cessation of maximum load and analyzed (ABL90 FLEX blood gas analyzer, Radiometer GmbH, Krefeld, Germany). Blood pressures (BP) was observed at rest, every 3 min during the IET and after the first 5 min of recovery period.

Quantification of comfort/discomfort

We used a published questionnaire published by [14] to quantify the following ten domains of comfort/discomfort of wearing a mask: humidity, heat, breathing resistance, itchiness, tightness, saltiness, feeling unfit, odor, fatigue, and overall discomfort. The participants were asked 10 min after each IET how they perceived the comfort in the test.

Statistical analysis

All values are expressed as means and standard deviations unless otherwise stated, and the significance level was defined as p < 0.05. Data were analyzed using Microsoft Office Excel® 2010 for Windows (Microsoft Corporation, Redmond, Washington, USA) and GraphPad Prism 8 (GraphPad Software Inc., California, USA). For distribution analysis, the D’Agostino–Pearson normality test was used. For normal distribution, comparisons were made using one-way repeated measures ANOVA with Turkey’s post hoc test for multiple comparisons. Otherwise, the Friedman non-parametric test and Dunn’s post hoc test were used. The study was powered to detect a difference of 10% in VO2max/kg between nm and ffpm.

Results

Pulmonary function

The results of the pulmonary function tests are shown in Table 2. Both sm and ffpm significantly reduce the dynamic lung parameters. The average reduction of FVC was −8.8 ± 6.0% with sm and −12.6 ± 6.5% with ffpm. FEV1 was −7.6 ± 5.0% lower with sm and −13.0 ± 9.0% with ffpm compared to no mask. The peak flow measurement showed that both sm and ffpm significantly reduced the PEF (−9.7 ± 11.2% and −21.3 ± 12.4%, respectively).
Table 2
Spirometry results
Parameter
Unit
nm
sm
ffpm
ANOVA
nm vs sm
nm vs. ffpm
sm vs ffpm
FVC
l
6.1 ± 1.0
5.6 ± 1.0
5.3 ± 0.8
< 0.001
0.003
< 0.001
0.032
FEV1
l
4.3 ± 0.7
4.0 ± 0.7
3.7 ± 0.6
0.001
0.001
0.003
0.068
TIFF
%
70.6 ± 9.7
71.2 ± 6.9
69.7 ± 4.9
0.635
0.934
0.900
0.520
PEF
l/s
9.7 ± 1.6
8.7 ± 1.4
7.5 ± 1.1
< 0.001
0.026
0.001
0.040
Spirometry results of health volunteers wearing no mask (nm), a surgical mask (sm) and a FFP2/N95 mask (ffpm) depicted as mean ± standard deviation
Significant results are indicated in bold
FVC forced vital capacity, FEV1 forced expiratory volume in 1 s, TIFF Tiffenau index, PEF peak expiratory flow, l liter, s second

Incremental exertion test

The results of IET under different conditions are depicted in Table 3. None of the masks had impact on the examined parameters under resting condition. The average duration of IET compared to the test without mask was slightly decreased by −29 ± 40 s with sm (p = 0.07) and significantly decreased by −52 ± 45 s with ffpm (p = 0.005). Under maximum load, there was a large reduction of the performance measures Pmax and VO2max, especially with ffpm (Fig. 2). Furthermore, these parameters were significantly reduced in ffpm compared to sm.
Table 3
Results of the incremental exercise test
Incremental exertion test
Unit
nm
sm
ffpm
ANOVA
nm
vs sm
nm
vs. ffpm
sm
vs. ffpm
Rest
 Hemodynamic parameters
  HR
bpm
66.2 ± 9.3
66.2 ± 11.8
66.2 ± 7.2
1.000
1.000
1.000
1.000
  SV
ml
100 ± 17.7
105 ± 22.3
103 ± 21.0
0.280
0.354
0.310
0.863
  CO
l/min
6.3 ± 0.7
6.6 ± 0.7
6.6 ± 0.9
0.314
0.542
0.248
0.985
  avDO2
%
5.4 ± 1.5
4.7 ± 1.3
5.1 ± 0.9
0.346
0.307
0.837
0.623
  SBP
mmHg
117 ± 8.7
122 ± 12.3
121 ± 12.0
0.399
0.474
0.529
0.977
  DBP
mmHg
81.9 ± 6.1
80.1 ± 6.6
81.0 ± 6.2
0.569
0.494
0.836
0.907
 Pulmonary parameters
  VE
l/min
10.5 ± 2.5
10.3 ± 2.6
10.4 ± 1.9
0.822
0.898
0.967
0.958
  Breathing frequency
brpm
14.8 ± 2.2
12.9 ± 2.9
12.5 ± 2.7
0.006
0.051
0.016
0.601
  VT
l
0.7 ± 0.2
0.8 ± 0.2
0.9 ± 0.2
0.146
0.465
0.125
0.770
 Metabolic parameters
  pH
 
7.41 ± 0.02
7.44 ± 0.06
7.42 ± 0.02
0.166
0.278
0.558
0.422
  PCO2
mmHg
40.2 ± 3.4
39.3 ± 3.6
39.3 ± 2.2
0.094
0.179
0.213
0.998
  PO2
mmHg
111 ± 4.3
117 ± 23.1
122 ± 22.1
0.465
0.824
0.487
0.787
  Lactate
mmol/l
1.00 ± 0.27
0.78 ± 0.26
1.04 ± 0.52
0.125
0.003
0.962
0.281
Maximum load
 Peformance
  Pmax
W
277 ± 45.9
269 ± 45.1
263 ± 41.7
0.002
0.071
0.005
0.018
  Pmax/kg
W/kg
3.40 ± 0.5
3.30 ± 0.5
3.22 ± 0.4
0.001
0.066
0.005
0.019
  VO2max/kg
(ml/min)/kg
39.7 ± 5.8
37.9 ± 6.0
34.5 ± 5.3
< 0.001
0.063
0.001
0.013
 Hemodynamic parameters
  HR
bpm
187 ± 8.3
183 ± 9.2
182 ± 11.2
0.106
0.031
0.107
0.964
  SV
ml
151 ± 26.4
165 ± 35.0
164 ± 20.4
0.086
0.166
0.074
0.979
  CO
l/min
25.8 ± 4.2
27.3 ± 5.6
27.0 ± 3.8
0.342
0.435
0.422
0.964
  avDO2
%
12.8 ± 2.8
11.5 ± 2.2
10.5 ± 2.0
0.002
0.084
0.007
0.172
  SBP
mmHg
214 ± 18.2
212 ± 28.5
210 ± 18.8
0.901
0.984
0.905
0.954
  DBP
mmHg
88.8 ± 9.6
95.8 ± 36.7
89.8 ± 8.8
0.582
0.779
0.959
0.847
 Pulmonary parameters
  VE
l/min
131 ± 27.8
114 ± 23.3
98.8 ± 18.6
0.001
0.048
0.003
0.009
  Breathing frequency
brpm
40.9 ± 5.1
39.3 ± 6.2
36.8 ± 5.9
0.019
0.518
0.024
0.138
  VT
l
3.2 ± 0.7
2.9 ± 0.5
2.7 ± 0.4
0.016
0.255
0.021
0.102
 Metabolic parameters
  pH
 
7.27 ± 0.05
7.32 ± 0.10
7.31 ± 0.06
0.158
0.216
0.065
0.989
  PCO2
mmHg
34.2 ± 3.8
34.3 ± 5.9
34.9 ± .0
0.726
0.999
0.560
0.943
  PO2
mmHg
107 ± 20.5
116 ± 23.7
116 ± 23.2
0.502
0.714
0.339
0.996
  Lactate
mmol/l
12.8 ± 3.09
11.0 ± 3.91
10.8 ± 3.12
0.049
0.132
0.105
0.985
Recovery
 Hemodynamic parameters
  HRR-1 min
bpm
−39.7 ± 15.9
−38.1 ± 9.2
−39.9 ± 11.2
0.203
0.055
0.611
0.781
  HRR-5 min
bpm
−72.5 ± 24.1
−77.6 ± 11.5
−77.3 ± 10.9
0.874
0.938
0.855
0.991
Results of the incremental exercise test of health volunteers wearing no mask (nm), a surgical mask (sm) and a FFP2/N95 mask (ffpm) depicted as mean ± standard deviation
Significant results are indicated in bold
HR heart rate, P power, SV stroke volume, CO cardiac output, avDO2 arterio-venous oxygen content difference, SBP systolic blood pressure, DBP diastolic blood pressure, VO2 oxygen uptake, VE ventilation, VT tidal volume, PCO2 partial pressure of carbon dioxide, PO2 partial pressure of oxygen, HRR heart rate recovery, bpm beats per minute, W Watt, brpm breaths per minute
Assessment of the hemodynamic parameters (Table 3) showed that ffpm decreased avDO2 by 16.7 ± 11.2% compared to nm. Stroke volume and cardiac output and cardiac work did not differ significantly (nm: 4.3 ± 0.8 J, sm: 4.7 ± 1.4 J, ffpm: 4.6 ± 0.9 J; p = 0.29).
The masks showed a marked effect on pulmonary parameters: VE for both sm and ffpm was significantly reduced by −12.0 ± 12.6% and −23.1 ± 13.6%, respectively, compared to nm (see Table 3; Fig. 1). Compared to nm, tests with ffpm showed a significant reduction in breathing frequency with an additional decrease in tidal volume (−9.9 ± 11.3% and −14.4 ± 13.0%, respectively). At the same time, a longer inhalation time was observed (sm: 12 ± 15%, p = 0.043; ffpm: 19 ± 16%, p = 0.005). There were no differences in exhalation time.
Measurements of the metabolic parameters pH, PCO2, PO2 and lactate and the heart rate recovery did not differ significantly between the three tests (Table 3).

Perceived discomfort

Subjective ratings for different sensations and overall discomfort for sm and ffpm compared to nm are depicted in Table 4. In general, the negative ratings for all items of discomfort increased consistently and significantly from sm to ffpm. There were several-fold negative reports for the ffpm compared to nm and sm for breathing resistance. The relative aggravation in overall discomfort compared to the standard procedure for spiroergometric tests is shown in Fig. 2.
Table 4
Perceived discomfort
Discomfort
nm
sm
ffpm
ANOVA
nm vs sm
nm vs ffpm
sm vs ffpm
Humid
2.4 ± 2.0
4.9 ± 3.2
5.9 ± 2.2
0.003
0.069
0.001
0.402
Hot
2.0 ± 1.3
4.2 ± 2.4
6.2 ± 2.3
< 0.001
0.012
< 0.001
0.024
Breath resistance
1.7 ± 1.2
5.4 ± 1.9
7.4 ± 2.5
< 0.001
0.001
< 0.001
0.045
Itchy
1.1 ± 1.0
3.4 ± 3.1
4.9 ± 2.6
0.002
0.030
0.001
0.331
Tight
1.9 ± 1.8
3.9 ± 2.6
6.5 ± 2.3
< 0.001
0.035
< 0.001
0.021
Salty
0.7 ± 1.1
1.6 ± 1.5
3.5 ± 2.8
0.003
0.261
0.012
0.023
Unfit
1.4 ± 1.2
3.3 ± 2.3
5.4 ± 2.3
< 0.001
0.009
< 0.001
0.016
Odor
1.4 ± 2.2
1.2 ± 0.9
3.6 ± 2.8
0.011
0.956
0.056
0.036
Fatigue
2.7 ± 2.2
5.8 ± 2.5
6.5 ± 2.6
< 0.001
0.002
0.001
0.394
Overall discomfort
2.8 ± 2.2
5.2 ± 2.1
7.0 ± 1.7
< 0.001
0.012
< 0.001
0.005
Results of the questionnaire [14] quantitating ten domains of comfort/discomfort of wearing a surgical mask (sm) and a FFP2/N95 mask (ffpm) compared to no mask on a scale from 0 (no discomfort at all) to 10 (maximal discomfort) depicted as mean ± standard deviation
Significant results are indicated in bold

Discussion

This first randomized cross-over study assessing the effects of surgical masks and FFP2/N95 masks on cardiopulmonary exercise capacity yields clear results. Both masks have a marked negative impact on exercise parameters such as maximum power output (Pmax) and the maximum oxygen uptake (VO2max/kg). FFP2/N95 masks show consistently more pronounced negative effects compared to surgical masks. Both masks significantly reduce pulmonary parameters at rest (FVC, FEV1, PEF) and at maximum load (VE, BF, TV). Furthermore, wearing the masks was perceived as very uncomfortable with a marked effect on subjective breathing resistance with the FFP2/N95 mask.

Pulmonary function

Spirometry showed reduced FVC, FEV1 and PEF with the surgical mask and even greater impairments with the FFP2/N95 mask. Wearing the FFP2/N95 mask resulted in a reduction of VO2max by 13% and of ventilation by 23%. These changes are consistent with an increased airway resistance [15]. Studies testing increased upper airway obstruction induced by added resistance at the mouth report similar effects on the lung functions parameter with increased breathing resistance [16]. The reduction in ventilation resulted from a lower breathing frequency with corresponding changes of the inhaling and exhaling time and a reduced tidal volume. This is in agreement with the effects of respiratory protective devices or additional external breathing resistance [16, 17]. The increased breathing resistance, which is likely higher during stress, leads to an elevated breathing work and a limitation of the ventilation. The data of this study are obtained in healthy young volunteers, the impairment is likely to be significantly greater, e.g., in patients with obstructive pulmonary diseases [18]. From our data, we conclude that wearing a medical face mask has a significant impact on pulmonary parameters both at rest and during maximal exercise in healthy adults.

Cardiac function

Increased breathing resistance in ffpm and sm requires more work of the respiratory muscles compared to nm leading to higher oxygen consumption. Additionally, a significant proportion of cardiac output is directed via different mechanisms, e.g., sympathetically induced vasoconstriction, to the respiratory musculature [19]. Furthermore, the increased breathing resistance may augment and prolong inspiratory activity leading to more negative intrathoracic pressure (ITP) for longer durations. This assumption is supported by the findings on inspiration times which were higher while wearing a fm. Prolonged and more negative ITP increases the cardiac preload and may lead to higher SV at the one hand which is consistent with our results showing a statistical trend towards higher SV while wearing ffpm or sm [20, 21]. In addition, cardiac afterload increases because of an increased transmural left-ventricular pressure resulting in enhanced myocardial oxygen consumption [22]. In these healthy volunteers, functional cardiac parameters do not differ significantly at baseline, at maximal load and during recovery. However, there is a non-significant trend towards a higher cardiac work (Joule) compared to the test without mask. This is of relevance since significantly less watts (−5%) was achieved in the tests with masks. The relation of cardiac power to the total power is approximately 10% lower with ffpm. These data suggest a myocardial compensation for the pulmonary limitation in the healthy volunteers. In patients with impaired myocardial function, this compensation may not be possible.

Performance

The measurements show that surgical masks, and to a greater extent FFP2/N95 masks, reduce the maximum power. Pmax (Watt) depends on energy consumption and the maximum oxygen uptake (VO2max). The effect of the masks was most pronounced on VO2max. Since the cardiac output was similar between the conditions, the reduction of Pmax was primarily driven by the observed reduction of the arterio-venous oxygen content (avDO2). Therefore, the primary effect of the face masks on physical performance in healthy individuals is driven by the reduction of pulmonary function. In addition, the auxiliary breathing muscles have been described to induce an additional afferent drive which can contribute to an increase of the fatigue effect [2325].
The performance of several different populations may be significantly affected by face masks. For athletes the use of fm will reduce physical performance. Less pronounced but mechanistically similar effects have been observed for mouthguards [2628]. The increased breathing resistance is especially problematic for patients with chronic obstructive pulmonary diseases. Patients with diffusion disorders have reduced capacity to compensate due to the reduced tidal volume. Another example of a population at risk is patients with heart failure. The observed mechanisms may lead to more severe symptoms in individuals with impaired capacity for myocardial compensation.

Discomfort

Health care professionals and others are faced with significant psychological distress during viral outbreaks [29]. Measures to maintain the quality of life both during emergency situations and long term care are increasingly important. Adequate personal protective equipment and adequate rest are considered keys to reduce the risk of adverse psychological outcomes [29]. Our sample primarily consisted of physicians working at a university hospital who are very familiar with medical masks and have a positive attitude towards personal protection. Our data show that FM leads to severe subjective discomfort during exercise. FFP2/N95 masks are perceived as more uncomfortable than sm. In particular, breathing resistance, heat, tightness and overall discomfort are the items with the greatest influence on subjective perception. This finding is in agreement with the literature [14, 30]. Wearing of fm is perceived as subjectively disturbing and is accompanied by an increased perception of exertion. It is likely that the masks negatively impact on the dynamics of perception especially at the limit of exercise tolerance [31, 32]. In addition to the severe impact on ventilation, the data suggest the associated discomfort as a second important reason for the observed impairment of physical performance.

Limitations of the study

The sample consisted of relatively young, healthy, male participants. The data cannot be extrapolated to other populations but set the stage to assess the effects of the face masks in elderly and in patients with pulmonary and with cardiac diseases. This study is the largest cross-over study to date comparing acute cardiopulmonary effects with and without common face masks, however, independent repetition and larger sample size is always welcome. The external validity concerning surgical masks (relevant leakage to eyes and ears in daily life) may be reduced because of the laboratory conditions where the sm was completely sealed by the spirometry mask. Cardiac parameters obtained by impedance cardiography may be overestimated using absolute values [33]. However, thoracic impedance cardiography is well established for the quantification of intra-individual changes in SV and CO [3436].

Conclusion

Medical face masks have a marked negative impact on cardiopulmonary capacity that significantly impairs strenuous physical and occupational activities. In addition, medical masks significantly impair the quality of life of their wearer. These effects have to be considered versus the potential protective effects of face masks on viral transmissions. The quantitative data of this study may, therefore, inform medical recommendations and policy makers.

Acknowledgement

Open Access funding provided by Projekt DEAL. We thank the volunteers from the staff of Leipzig University who participated in the study.

Compliance with ethical standards

Conflict of interest

None.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

Neuer Inhalt

Print-Titel

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat CDC (2020) Recommendation regarding the use of cloth face coverings, especially in areas of significant community-based transmission CDC (2020) Recommendation regarding the use of cloth face coverings, especially in areas of significant community-based transmission
2.
Zurück zum Zitat ECDC (2020) Using face masks in the community—reducing COVID-19 transmission from potentially asymptomatic or pre-symptomatic people through the use of face masks ECDC (2020) Using face masks in the community—reducing COVID-19 transmission from potentially asymptomatic or pre-symptomatic people through the use of face masks
3.
Zurück zum Zitat RKI (2020) Robert Koch-Institut: Mund-Nasen-Bedeckung im öffentlichen Raum als weitere Komponente zur Reduktion der Übertragungen von COVID-19. Strategie-Ergänzung zu empfohlenen Infektionsschutzmaßnahmen und Zielen (3. Update). Epid Bull 19:3–5. https://doi.org/10.25646/673CrossRef RKI (2020) Robert Koch-Institut: Mund-Nasen-Bedeckung im öffentlichen Raum als weitere Komponente zur Reduktion der Übertragungen von COVID-19. Strategie-Ergänzung zu empfohlenen Infektionsschutzmaßnahmen und Zielen (3. Update). Epid Bull 19:3–5. https://​doi.​org/​10.​25646/​673CrossRef
4.
Zurück zum Zitat WHO (2020) Advice on the use of masksin the context of COVID-19 WHO (2020) Advice on the use of masksin the context of COVID-19
8.
Zurück zum Zitat CDC (2019) Determination of particulate filter efficiency level of N95 series filters against solid particulates for non-powered, air-purifying respirators standard CDC (2019) Determination of particulate filter efficiency level of N95 series filters against solid particulates for non-powered, air-purifying respirators standard
10.
12.
Zurück zum Zitat Blocken BMF van Druenen T, Marchal T (2020) Towards aerodynamically equivalent COVID-19 1.5 m social distancing for walking and running Blocken BMF van Druenen T, Marchal T (2020) Towards aerodynamically equivalent COVID-19 1.5 m social distancing for walking and running
13.
20.
Zurück zum Zitat Convertino VA, Cooke WH, Lurie KG (2005) Inspiratory resistance as a potential treatment for orthostatic intolerance and hemorrhagic shock. Aviat Space Environ Med 76(4):319–325PubMed Convertino VA, Cooke WH, Lurie KG (2005) Inspiratory resistance as a potential treatment for orthostatic intolerance and hemorrhagic shock. Aviat Space Environ Med 76(4):319–325PubMed
Metadaten
Titel
Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity
verfasst von
Sven Fikenzer
T. Uhe
D. Lavall
U. Rudolph
R. Falz
M. Busse
P. Hepp
U. Laufs
Publikationsdatum
06.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 12/2020
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-020-01704-y

Weitere Artikel der Ausgabe 12/2020

Clinical Research in Cardiology 12/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.